Psychedelic drug stocks represent (by far) the best new opportunity in life sciences today. Institutional capital is flooding into the sector. But market analysts are asleep-at-the-wheel here.
Field Trip closes on a CAD$95 million bought deal financing, nearly double the original CAD$50 million offering.
A wide range of psychedelics such as psilocybin and ayahuasca are now officially the lowest local law enforcement in the nation’s capital as of Monday.
Scientists have used advanced computer simulations to better understand the neurobiological mechanisms underlying the psychedelic experience.